Tirzepatide Pill
Delivered every 23 days. Cancel anytime.
$139.00
every 23 days
$139.00
$499.00
one-time purchase
About This Product
What's Included
- ✓ Tirzepatide Sublingual RDT (Rapid Dissolving Tablets), 13.4mg–46.7mg — 4 tablets per homekit
- ✓ Telehealth Access
Strength varies from 13.4mg to 46.7mg and is dependent on the month ordered.
Procedure
Place one rapid-dissolving tablet under the tongue and allow it to fully dissolve. Do not chew or swallow the tablet whole, and avoid eating or drinking while it dissolves. Instructional tutorial provided after purchase.
Purpose
Our Tirzepatide Sublingual RDT is a needle-free option for patients seeking the benefits of tirzepatide without injections. It is taken once weekly and dissolves under the tongue.
Tirzepatide has a dual approach with both GLP and GIP benefits. As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, it mimics the action of these incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying. This multifaceted approach helps improve blood sugar control and supports weight loss.
Dosing Schedule
Once a week — taken on the same day each week. Detailed dosing schedule provided with homekit.
*Each homekit ordered contains 4 tablets (1 month supply)
Diet and Exercise
Healthy eating and activity are recommended.
Benefits
- Weight Loss
- May improve Blood Pressure
- May improve Cholesterol
- Improves Blood Sugar
Most Common Side Effects
The most common side effects of Tirzepatide are usually gastrointestinal, including nausea.
Recommendations to limit Nausea: Eat bland, low-fat foods, like crackers, toast and rice. Eat foods that contain water, like soup and gelatin. Avoid laying down after eating. Eat slowly. Go outdoors for fresh air.
Physician Consent for Treatment: A physician may contact you within 24 hours of purchase if additional information is needed.
Important — Titration Schedule
This product follows a titration schedule. All patients must start with the Month 1 dose. After Month 1, the strength increases gradually in Month 2, 3, and 4. The maintenance dose can be ongoing for up to 8 months depending on your goals.
Shipping
This product requires refrigeration. It will be shipped 2-Day or Overnight with appropriate cold-chain packaging. Please refrigerate immediately upon receipt.
What is Tirzepatide?
Tirzepatide is a medication that belongs to a class of drugs called glucagon-like peptide-1 receptor agonist (GLP-1 RA) and glucose-dependent insulinotropic polypeptide (GIP) receptor dual agonists, used for the treatment of type 2 diabetes mellitus.
Tirzepatide works by mimicking the action of two naturally occurring incretin hormones, GLP-1 and GIP, helping regulate blood sugar levels and appetite.
The Science Behind Tirzepatide
Note: The clinical trial data described below were generated using FDA-approved subcutaneous (injectable) tirzepatide. The safety and efficacy of compounded sublingual tirzepatide have not been established in clinical trials, and bioavailability may differ from the injectable formulation. Individual results may vary.
1. Glycemic Control
In clinical trials of injectable tirzepatide, the medication reduced HbA1c by targeting multiple pathways involved in blood sugar regulation.
2. Weight Loss
Injectable tirzepatide has been associated with significant weight loss in clinical studies, alongside improvements in insulin sensitivity.
3. Convenience
This sublingual formulation is taken once weekly and dissolves under the tongue, offering a needle-free dosing option.
4. Potential Cardiovascular Benefits
Research on injectable tirzepatide suggests it may reduce the risk of major adverse cardiovascular events in people with type 2 diabetes. These findings are specific to the injectable product.
5. Flexibility in Dosing
Tirzepatide offers flexibility in dosing, allowing healthcare providers to tailor treatment to individual patient needs.
How Does Tirzepatide Work?
GLP-1 Receptor Activation
When Tirzepatide activates the GLP-1 receptor: insulin secretion increases in response to high blood glucose; glucagon secretion decreases; gastric emptying is delayed, controlling post-meal blood sugar spikes; and appetite is suppressed through brain GLP-1 receptor activation.
GIP Receptor Activation
The activation of the GIP receptor by Tirzepatide enhances insulin secretion in response to high blood sugar and improves insulin sensitivity in peripheral tissues such as muscle and fat.
Synergistic Effects
The dual action targeting both GLP-1 and GIP receptors provides a synergistic effect in managing blood sugar levels — more effective than medications targeting only one pathway. By combining these mechanisms, Tirzepatide effectively lowers blood glucose, aids in weight loss, and improves overall metabolic health.
References
This compounded medication contains Tirzepatide formulated as a sublingual rapid-dissolving tablet for individual patients who may not tolerate standard formulations or who require a customized therapeutic approach. It is prepared in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act and dispensed solely pursuant to a valid patient-specific prescription from a licensed healthcare provider.
Our compounded formulation is not affiliated with, endorsed by, or intended to replace the FDA-approved product manufactured by Eli Lilly. Compounded sublingual tirzepatide is not an FDA-approved route of administration, and its safety, efficacy, and bioavailability have not been established in clinical trials.
This medication is not made for resale, bulk distribution, or office use, and is compounded exclusively to meet the clinical needs of individual patients when commercially available alternatives are not appropriate.